Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer
Bontenbal, M, Andersson, M, Wildiers, J, Cocconi, G, Jassem, J, Paridaens, R, Rotmensz, N, Sylvester, R, Mouridsen, HT, Klijn, JGM, van Oosterom, ATVolume:
77
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.1998.375
Date:
June, 1998
File:
PDF, 1.14 MB
english, 1998